Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Pharma-Bio Serv (PBSV) over the last 12 years, with Q4 2025 value amounting to -$528746.0.

  • Pharma-Bio Serv's Gains from Investment Securities rose 2003.53% to -$528746.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$661224.0, marking a year-over-year decrease of 117266.15%. This contributed to the annual value of $138419.0 for FY2019, which is 32207.35% up from last year.
  • According to the latest figures from Q4 2025, Pharma-Bio Serv's Gains from Investment Securities is -$528746.0, which was up 2003.53% from $528746.0 recorded in Q2 2025.
  • In the past 5 years, Pharma-Bio Serv's Gains from Investment Securities ranged from a high of $528746.0 in Q2 2025 and a low of -$661224.0 during Q4 2024